Related Experiment Video
Updated: Apr 7, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[The complex management of cirrhosis patients]
1Service d'hépato-gastroentérologie (CHU Poitiers), Laboratoire Inflammation, tissus épithéliaux et cytokines EA 4331 (pôle biologie-santé), CHU de Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France.
Abstract:
All chronic liver diseases, whatever their causes, can lead to cirrhosis, when they evolve untreated for more than 10 to 20 years. The diagnosis of cirrhosis is based on the histology obtained from a liver biopsy, or on composite scores or elasticity. While these indirect tests are approved they are only reimbursed for viral hepatitis C associated or not with HIV.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Pancreatitis II: Collaborative Care
Assessment:
Cystic Fibrosis: Management
Sinus disease and chronic...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

